10-112950906-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001367943.1(TCF7L2):c.150T>A(p.Asn50Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,460,362 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 29)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
TCF7L2
NM_001367943.1 missense
NM_001367943.1 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 1.31
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 20 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.150T>A | p.Asn50Lys | missense_variant | 1/15 | ENST00000355995.9 | |
LOC124902502 | XR_007062291.1 | n.667A>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCF7L2 | ENST00000355995.9 | c.150T>A | p.Asn50Lys | missense_variant | 1/15 | 1 | NM_001367943.1 | ||
ENST00000369391.3 | n.200A>T | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460362Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726330
GnomAD4 exome
AF:
AC:
20
AN:
1460362
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
726330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.150T>A (p.N50K) alteration is located in exon 1 (coding exon 1) of the TCF7L2 gene. This alteration results from a T to A substitution at nucleotide position 150, causing the asparagine (N) at amino acid position 50 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;D;.;T;.;.;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;.;M;M;.;M;M;M;M;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D;D;.;D;D;D;D;D;.
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D;.;D;D;D;D;D;.
Sift4G
Benign
T;T;T;T;T;T;T;T;T;D;T;T
Polyphen
1.0, 0.99, 1.0
.;D;.;.;.;D;.;.;.;.;D;.
Vest4
MutPred
Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);Gain of ubiquitination at N50 (P = 0.0069);
MVP
MPC
1.7
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.